Abstract

The mechanistic target of Rapamycin (mTOR) is a ubiquitously-conserved serine/threonine kinase, which has a central function in integrating growth signals and orchestrating their physiologic effects on cellular level. mTOR is the core component of differently composed signaling complexes that differ in protein composition and molecular targets. Newly identified classes of mTOR inhibitors are being developed to block autoimmune diseases and transplant rejections but also to treat obesity, diabetes, and different types of cancer. Therefore, the selective and context-dependent inhibition of mTOR activity itself might come into the focus as molecular target to prevent severe diseases and possibly to extend life span. This review provides a general introduction to the molecular composition and physiologic function of mTOR complexes as part of the Special Issue “2018 Select Papers by Cells’ Editorial Board Members”.

Highlights

  • The mechanistic target of Rapamycin is a ubiquitously-conserved serine/threonine kinase, which has a central function in integrating growth signals and orchestrating their physiologic effects on cellular level. mTOR is the core component of differently composed signaling complexes that differ in protein composition and molecular targets

  • The PI3K-related kinases (PIKK)-type kinase mTOR plays a central role as coordinator of cellular metabolism by integrating distinct extracellular stimuli and intracellular signals for the initiation of a concerted and adjusted response

  • Because of its crucial role in normal physiology, the dysregulation of mTOR signaling is often associated with certain diseases as well as the molecular process of aging

Read more

Summary

Assembly of the mTOR Signaling Complexes TORC1 and TORC2

The coordination of cell growth, cell size, organ shape and body plan is largely controlled by one serine/threonine kinase, the mechanistic target of Rapamycin (mTOR), which is, historically, known as a mammalian target of rapamycin [1]. It has been described as an atypical protein kinase, because it is closely related to the phosphatidylinositol 3-kinase (PI3K) family of lipid kinases and represents the founding member of the small family of PI3K-related kinases (PIKK) [2].

Cellular
Upstream Factors
FOR PEER REVIEW
Downstream
FOR then
Involvement of mTOR Activity in Obesity and Diabetes
Pharmacological Use of Different mTOR Inhibitor Families
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.